Vanguard Mega Cap Value Index Fund (MGV) is an exchange-traded fund that seeks to track the performance of the CRSP US Mega Cap Value Index, comprising large-cap U.S. stocks exhibiting value characteristics such as low price-to-book ratios and low forecasted growth; it offers investors passive exposure to mega-cap value equities through a diversified portfolio of approximately 200 holdings, including major brands like Berkshire Hathaway, JPMorgan Chase, Exxon Mobil, Johnson & Johnson, and Procter & Gamble. The fund provides core products including shares traded on the NYSE Arca exchange under the ticker MGV, with services encompassing daily liquidity, low expense ratio of 0.07%, dividend reinvestment options, and tax-efficient share class structures for institutional and retail investors targeting long-term value-oriented strategies. Headquartered in Malvern, Pennsylvania, as part of The Vanguard Group, Inc., founded in 1975, MGV operates primarily in the U.S. equity market, serving individual investors, financial advisors, and institutions across North America with no international geographic expansion beyond U.S.-listed securities.
In recent developments, MGV benefited from Vanguard's strategic expansion into enhanced indexing capabilities, including the launch of new factor-based ETFs in 2024 that complement its value-focused offerings; the fund saw portfolio rebalancing in response to market shifts, with increased weightings in energy and financial sectors amid 2025 economic volatility. Vanguard announced a major partnership with major index providers to refine mega-cap benchmarks, improving tracking accuracy for MGV, while completing the acquisition of additional analytics tools to support value stock selection amid rising interest rates. No significant name changes or reorganizations occurred, but the fund experienced asset growth exceeding 10% year-over-year as of late 2025, reflecting inflows from value rotation strategies.